HEARTBEAT.BIO

Our vision is to transform the drug discovery paradigm in heart failure by building the most advanced TechBio platform where proprietary human biology, AI-driven insights, and advanced automation converge to close the innovation gap in this high-impact disease area... Our mission is to accelerate the development of breakthrough therapies that not only enable faster, more predictive, and cost-efficient drug discovery but also improve clinical success and significantly enhance patient health outcomes... By integrating our highly representative cardiac model with specialized assays at a fully automated, industry-leading 384-well scale, we have created one of the most robust, scalable, and cost effective platforms for heart-disease drug discovery and candidate testing.

Also known as: HeartBeat.bio AG

Registration numbers: 547992x (W)

VAT numbers: ATU76355347

Primary location: Vienna Austria